Cemex stock hits 52-week high at $9.68

Published 15/10/2025, 14:34
Cemex stock hits 52-week high at $9.68

Cemex SAB de CV ADR stock reached a significant milestone, hitting a 52-week high of $9.68. The $13.86 billion market cap construction materials giant has demonstrated remarkable momentum, with an 83.62% surge over the past six months and a 63.36% increase over the past year. According to InvestingPro analysis, the company currently appears slightly undervalued, with a P/E ratio of 15.74 and an overall Financial Health Score of "GREAT." The stock’s rise to this new high highlights investor confidence and market optimism surrounding Cemex’s performance and future prospects. As the company continues to navigate the complexities of the global construction materials market, this latest development marks a positive trajectory in its financial journey. Discover 8 additional key insights about Cemex with InvestingPro’s exclusive Research Report, part of their comprehensive analysis of 1,400+ top stocks.

In other recent news, CEMEX has seen significant developments that could impact investor decisions. BofA Securities upgraded CEMEX from Neutral to Buy, raising its price target to $10.80, citing successful cost savings efforts and adjusted estimates ahead of its third-quarter earnings. Additionally, S&P Global Ratings upgraded CEMEX’s long-term national credit rating to ‘mxAAA’ from ‘mxAA+’, reflecting changes in the agency’s rating methodology.

Furthermore, CEMEX announced the second installment of its cash dividend for holders of its Ordinary Participation Certificates (CPOs) and American Depositary Shares (ADSs), with a total payout of $32.5 million. This installment is part of a previously approved $130 million cash dividend. In another announcement, CEMEX clarified that it found no internal causes for unusual trading activity in its securities on the Mexican Stock Exchange, attributing the fluctuations to market conditions.

These recent developments provide a comprehensive view of the company’s strategic moves and financial health.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.